Taiwan Treats Patient With New Cancer-fighting Radiotherapy System From Elekta

< BACK TO IMMIGRATION starstarstarstarstar   Government - Immigration Press Release
13th March 2009, 02:32am - Views: 592

People Immigration Elekta 1 image

Taiwan Treats Patient With New Cancer-Fighting Radiotherapy System From Elekta

STOCKHOLM, Mar. 12 /PRNewswire-AsiaNet/ --

         Revolutionary Treatment Brings Optimism to Taiwan Patients

    A patient with prostate cancer has received treatment using Elekta VMAT

(Volumetric Modulated Arc Therapy) at the National Taiwan University Hospital

(NTUH) in Taiwan. VMAT enables dramatically reduced treatment times and more

precise targeting of tumors by simultaneously controlling all aspects of the

treatment. It constantly changes the shape of the beam to conform to the

shape of the area that needs to receive radiation while at the same time

sparing the surrounding critical tissue. Like most organs, the prostate can

move during treatment. By delivering radiation in less time, VMAT technology

minimizes the opportunity for organ motion, which further enhances the

precision of the radiation treatment.

    NTUH treated the patient with the comprehensive Elekta VMAT solution that

includes ERGO++ treatment planning software. The ERGO++ treatment planning

system uses a special algorithm to perform fast, accurate dose calculations.

The patient was treated on Elekta Synergy(R), a multi-functional linear

accelerator that enables clinicians to both image and treat patients in the

same frame of reference, at the time of treatment.

    Jason Chia-Hsien Cheng, M.D., M.S., Ph.D. is Division Chief of the

Division of Radiation Oncology, Department of Oncology, and Assistant

Professor, Graduate Institute of Clinical Medicine at NTUH. He says, "Our

first patient undergoing VMAT is a 76-year-old retired gentleman with

prostate cancer. He is a father with many children. He was treated with

200cGy via a co-planar single arc, and the treatment time was less than three


    Taiwan's first VMAT patient benefited from improved technology, with

better conformity of tumor coverage and a shorter treatment time than the

current IMRT treatments allow, says Dr. Cheng. "We appreciate the advantages

of VMAT with shorter daily treatment times and the best target conformity. We

also see a large number of patients in our department, so it's important to

have efficient patient treatment flow."

    NTUH is one of the biggest hospitals in Taiwan, and more than 200 cancer

patients are treated with radiotherapy every day. "We are excited and honored

to be the first hospital in the Asian Pacific area to start a VMAT program,"

says Dr. Cheng. "In the future, we expect that the better dose coverage of

VMAT should bring better outcomes and sparing of critical organs in the head

and neck and other complex areas."

    The annual incidence of cancer is increasing worldwide, he adds. "If we

can treat patients more efficiently, we can help more people with precise,

comfortable treatment, and speed up our patient flow as well."

    About Elekta

    Elekta is a human care company pioneering significant innovations and

clinical solutions for treating cancer and brain disorders. The company

develops sophisticated, state-of-the-art tools and treatment planning systems

for radiation therapy and radiosurgery, as well as workflow enhancing

software systems across the spectrum of cancer care.

People Immigration Elekta 2 image

    Stretching the boundaries of science and technology, providing

intelligent and resource-efficient solutions that offer confidence to both

healthcare providers and patients, Elekta aims to improve, prolong and even

save patient lives, making the future possible today.

    Today, Elekta solutions in oncology and neurosurgery are used in over

5,000 hospitals globally, and every day more than 100,000 patients receive

diagnosis, treatment or follow-up with the help of a solution from the Elekta


    Elekta employs around 2,500 employees globally. The corporate headquarter

is located in Stockholm, Sweden, and the company is listed on the Nordic

Exchange under the ticker EKTAb. For more information about Elekta, please

SOURCE: Elekta

    CONTACT: Lena Schattauer

             Investor Relations, Elekta AB

             +46 8 587 257 22

             +46 70 595 51 00

             lena.schattauer@elekta.com, or 

             Jason Chai-Hsien Cheng

             M.D., Ph.D., National Taiwan University Hospital 

             +886-2-2312-3456 Ext, 6696



   Chinese - Traditional (http://asianetnews.net/Download.asp?ID=120784)

To view this and other AsiaNet releases please visit http://www.asianetnews.net

news articles logo NEWS ARTICLES
Contact News Articles |Remove this article